Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler
News

High body fat tied to slowed breast maturation in girls with obesity
- Author:
- Mitchel L. Zoler, PhD
Detailed hormonal and ultrasound assessment of 90 girls aged 8-14 years yields new evidence linking elevated...
News

Hypertension worsened by commonly used prescription meds
- Author:
- Mitchel L. Zoler, PhD
Close to 20% of U.S. adults with hypertension are on a prescription drug, such as NSAIDs, known to raise blood pressure, creating an opportunity...
News

Half of patients in hospital for COVID-19 get acute kidney injury
- Author:
- Mitchel L. Zoler, PhD
It’s bad news when hospitalized COVID-19 patients develop acute kidney injury, which can prove fatal or can lead to the development or worsening...
News
Twenty percent of dialysis patients are hesitant about COVID-19 vaccine
- Author:
- Mitchel L. Zoler, PhD
More than half of the patients who were concerned about being vaccinated cited concern over possible adverse...
News

Hyperphagia, anxiety eased with carbetocin in patients with Prader-Willi syndrome
- Author:
- Mitchel L. Zoler, PhD
Carbetocin, an intranasal oxytocin analogue, significantly cut hyperphagia and anxiety in patients with Prader-...
News
STEP 4: Ongoing semaglutide treatment extends weight loss
- Author:
- Mitchel L. Zoler, PhD
After weekly semaglutide injections produced an 11% average weight loss, continued use led to continued loss, while discontinuation meant regain...
News

Metyrapone for Cushing’s syndrome: Safe, effective in first test
- Author:
- Mitchel L. Zoler, PhD
In the first prospective study of metyrapone as therapy for Cushing’s syndrome it normalized mean urinary free...
News

High-intensity interval training cuts cardiometabolic risks in women with PCOS
- Author:
- Mitchel L. Zoler, PhD
Twelve weeks of high-intensity exercise by women with polycystic ovary syndrome produced benefits beyond what...
News

Ultraprocessed foods, many marketed as healthy, raise CVD risk
- Author:
- Mitchel L. Zoler, PhD
Framingham data show each regular, daily serving of ultraprocessed food – carbonated soft drinks, candies,...
News

Imaging alternative to AVS could boost detection of primary aldosteronism
- Author:
- Mitchel L. Zoler, PhD
Patients with PA need assessment for a unilateral adrenal source. Radiolabeled PET-CT did that as well as...
News
Eating fish tied to fewer CVD events in high-risk people
- Author:
- Mitchel L. Zoler, PhD
A report shows a significant link between eating two fish meals a week and fewer cardiovascular disease events for those with or at high risk for...
News

Big data ‘clinch’ link between high glycemic index diets and CVD
- Author:
- Mitchel L. Zoler, PhD
Data from nearly 120,000 adults worldwide in the PURE study forms the clearest evidence so far that a diet with less processed carbs is associated...
News

Thirteen percent of patients with type 2 diabetes have major ECG abnormalities
- Author:
- Mitchel L. Zoler, PhD
ECGs from more than 8,000 Dutch patients with type 2 diabetes, most without known cardiovascular disease, show that major abnormalities are not...
News

Obesity pegged as diabetes cause in almost half of U.S. cases
- Author:
- Mitchel L. Zoler, PhD
Data from two major U.S. epidemiology studies, MESA and NHANES, provide new evidence that obesity is the attributable cause for about 40% of...
News

More from DAPA-HF: Dapagliflozin quickly reduces heart failure events
- Author:
- Mitchel L. Zoler, PhD
Secondary analysis of DAPA-HF showed dapagliflozin significantly cut CV deaths or worsening heart failure within...